NCT03729713

Brief Summary

This study examines a home-based computerized cognitive rehabilitation intervention in adults with multiple sclerosis compared to placebo (videogame). Patients are assessed through pre-and post neuropsychological testing.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P75+ for not_applicable multiple-sclerosis

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 5, 2018

Completed
2.5 years until next milestone

Study Start

First participant enrolled

April 21, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

November 17, 2022

Status Verified

November 1, 2022

Enrollment Period

2 years

First QC Date

November 1, 2018

Last Update Submit

November 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cognitive Functioning

    Compare between groups differences in attention (auditory and visual working memory), processing speed (automatic and controlled speed), executive functioning (verbal fluency and mental flexibility), and memory (immediate and delayed verbal and visual modalities) at completion of intervention, 3 months and 6 months using standardized scores.

    6 Months

Secondary Outcomes (5)

  • Multiple Sclerosis Self-Efficacy Scale

    6 Months

  • Work Productivity and Activity Impairment Instrument

    6 months

  • Multiple Sclerosis Quality of Life Inventory

    6 months

  • Hospital Anxiety and Depression Scale

    6 months

  • Healthcare Utilization

    12 Months

Other Outcomes (2)

  • Six-minute Walk Test

    6 months

  • Timed Up & Go Test

    6 months

Study Arms (2)

Intervention

EXPERIMENTAL

Computerized Cognitive Rehabilitation

Other: Computerized cognitive rehabilitation

Placebo

SHAM COMPARATOR

Video game

Other: Sham placebo

Interventions

6 week course of cognitive rehabilitation focused on attention, learning, and memory

Intervention

an alternative home-based computer program not designed for cognitive remediation but of the same duration

Placebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Diagnosis of multiple sclerosis with cognitive complaint

You may not qualify if:

  • Patients unwilling to participate
  • Patients who cannot attend NPT sessions
  • Patients with severe cognitive impairment
  • Non-English speaking patients (testing materials are in English)
  • Patients with intact neuropsychological functioning at baseline on testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Robert Wood Johnson Medical School

New Brunswick, New Jersey, 08091, United States

RECRUITING

MeSH Terms

Conditions

Multiple SclerosisCognitive Dysfunction

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Central Study Contacts

Vikram Bhise, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Placebo controlled
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 1, 2018

First Posted

November 5, 2018

Study Start

April 21, 2021

Primary Completion

May 1, 2023

Study Completion

May 1, 2024

Last Updated

November 17, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations